Renata PLC (DSE: RENATA)

Market Cap	75.10B
Revenue (ttm)	38.44B
Net Income (ttm)	3.19B
Shares Out	114.70M
EPS (ttm)	27.82
PE Ratio	23.53
Forward PE	n/a
Dividend	9.20 (1.41%)
Ex-Dividend Date	Oct 22, 2024

Volume	6,841
Open	639.00
Previous Close	657.80
Day's Range	639.00 - 661.20
52-Week Range	608.30 - 1,217.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 28, 2025

About Renata

Renata PLC manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, a...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 7,859
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: RENATA

Financial Performance

In 2024, Renata's revenue was 37.71 billion, an increase of 14.37% compared to the previous year's 32.97 billion. Earnings were 3.62 billion, an increase of 54.57%.